PhaseFolio

A clearer view of biotech

See the landscape.
Build a stronger case.

Connect the evidence. Explore the assumptions. Bring a point of view you can stand behind to your next biotech decision.

Sign upExplore Atlas

Your next landscape starts with a question.

A new perspective starts with the pieces.
Three perspectives.
One connected ambition.AtlasFind the right comparisonWorkspaceDevelop the investment caseSentinelFollow what changes · in development

Built for the work in front of you

From scattered evidence
to a shared point of view.

Different questions need different tools. Start with the landscape, develop the case, and help shape what comes next.

Bring the landscape into focus

Less assembly.
More perspective.

Bring relevant trial records together. Turn scattered evidence into a comparison you can inspect, challenge, and carry into your next decision.

Explore Atlas
A landscape, connectedProduct illustration
Start with your question. Bring the relevant registry records into view.

Keep the thread

Conviction comes
from the connections.

A comparison is more useful when you can follow the evidence behind it. A scenario is easier to discuss when you can see the assumptions that change it.

PhaseFolio keeps that context close, so the next conversation can build on the work you’ve already done.

Find your starting point

The sources behind the landscape

A wider world
of evidence.

Starting with ClinicalTrials.gov. Building toward a more connected view of trials, biology, publications, and company context.

Available in AtlasClinicalTrials.gov

Trial records and study context, linked to the source.

Explore current coverage

On the roadmap

Planned additions to the Atlas source collection.

  • openFDA

    FDA public data

    Planned
  • CTIS

    European clinical trials

    Planned
  • EUCTR / EudraCT

    Historical European trials

    Planned
  • Open Targets

    Target and disease context

    Planned
  • ChEMBL

    Molecules and mechanisms

    Planned
  • PubMed

    Publication records and citations

    Planned
  • EMA

    European regulatory records

    Planned
  • SEC EDGAR

    Company filings and disclosures

    Planned
  • Company disclosures

    Primary company announcements

    Planned

Planned sources are not yet connected in Atlas. Coverage will expand as each source becomes available.

PhaseFolio and EB Research Partnership announcement

Featured Announcement · Nonprofit Access Program

PhaseFolio Begins Work With EB Research Partnership

EB Research Partnership will use PhaseFolio to examine valuation assumptions, compare scenarios, organize supporting evidence, and evaluate research programs at both the asset and portfolio level. Access is being provided on a complimentary basis through PhaseFolio’s nonprofit access program.

Read the Full Announcement

This collaboration supports internal evaluation and workflow feedback. It does not imply EB Research Partnership’s endorsement or independent validation of PhaseFolio’s methodologies or outputs.

Supported along the way

Credits and technical support;
no product endorsement implied.

Google for StartupsCloud Program participantMicrosoft for StartupsProgram memberCloudflare for StartupsProgram participant

Your next question is a good place to start

Bring a little more
perspective to the table.

Sign upExplore the products

For organization-wide access or a larger workflow, contact sales